{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:26:39Z","timestamp":1770434799538,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.sleep.2011.06.008","type":"journal-article","created":{"date-parts":[[2011,9,18]],"date-time":"2011-09-18T14:47:10Z","timestamp":1316357230000},"page":"920-923","source":"Crossref","is-referenced-by-count":15,"title":["Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia"],"prefix":"10.1016","volume":"12","author":[{"given":"Sherry","family":"Wang-Weigand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Watiss\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2011.06.008_b0005","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), 4th ed. (Text Revision). Washington, DC: American Psychiatric Association; 2000."},{"issue":"4","key":"10.1016\/j.sleep.2011.06.008_b0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11136-009-9462-6","article-title":"Association of insomnia with quality of life, work productivity, and activity impairment","volume":"18","author":"Bolge","year":"2009","journal-title":"Qual Life Res"},{"issue":"Suppl. 5","key":"10.1016\/j.sleep.2011.06.008_b0015","first-page":"S7","article-title":"Insomnia: definition, prevalence, etiology, and consequences","volume":"3","author":"Roth","year":"2007","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2011.06.008_b0020","unstructured":"Takeda Pharmaceuticals North America. Rozerem [package insert]. 2010. Deerfield, IL."},{"issue":"2","key":"10.1016\/j.sleep.2011.06.008_b0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuropharm.2004.09.007","article-title":"Neurochemical properties of ramelteon (TAK-375), a selective MT1\/MT2 receptor agonist","volume":"48","author":"Kato","year":"2005","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.sleep.2011.06.008_b0030","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/archpsyc.63.10.1149","article-title":"Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects","volume":"63","author":"Johnson","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"10.1016\/j.sleep.2011.06.008_b0035","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1185\/030079907X178874","article-title":"A 2-night, 3-period, crossover study of ramelteon\u2019s efficacy and safety in older adults with chronic insomnia","volume":"23","author":"Roth","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.sleep.2011.06.008_b0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.sleep.2005.09.004","article-title":"An efficacy, safety, and dose-response study of ramelteon in patients with chronic primary insomnia","volume":"7","author":"Erman","year":"2006","journal-title":"Sleep Med"},{"issue":"3","key":"10.1016\/j.sleep.2011.06.008_b0045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5665\/sleep\/32.3.351","article-title":"Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic, primary insomnia","volume":"32","author":"Mayer","year":"2009","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.sleep.2011.06.008_b0050","doi-asserted-by":"crossref","first-page":"495","DOI":"10.5664\/jcsm.26914","article-title":"Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia","volume":"3","author":"Zammit","year":"2007","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"10.1016\/j.sleep.2011.06.008_b0055","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.sleep.2006.01.003","article-title":"Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia","volume":"7","author":"Roth","year":"2006","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.sleep.2011.06.008_b0060","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4088\/JCP.07m03834","article-title":"Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: A 1-year, open-label study","volume":"70","author":"Richardson","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.sleep.2011.06.008_b0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5664\/jcsm.27390","article-title":"Effect of ramelteon on middle-of-the-night balance in older adults with chronic insomnia","volume":"5","author":"Zammit","year":"2009","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2011.06.008_b0070","unstructured":"European Medicines Agency Committe for Medicinal Products for Human Use. Guidelines on medicinal products for the treatment of insomnia. EMA\/CHMP\/16274\/2009. Effective: Feb 17 2011 [cited May 10 2011].Available from: URL: http:\/\/www.ema.europa.eu\/ema."},{"key":"10.1016\/j.sleep.2011.06.008_b0075","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration. Guidelines for the clinical evaluation of hypnotic drugs. HEW(FDA) 78-3051. Effective: Sep 1 1977 [cited May 10 2011].Available from: URL: www.fda.gov."},{"issue":"6","key":"10.1016\/j.sleep.2011.06.008_b0080","doi-asserted-by":"crossref","first-page":"622","DOI":"10.5664\/jcsm.26974","article-title":"Relationship between reported and measured sleep times: the sleep heart health study (SHHS)","volume":"3","author":"Silva","year":"2007","journal-title":"J Clin Sleep Med"},{"issue":"Suppl. 3","key":"10.1016\/j.sleep.2011.06.008_b0085","doi-asserted-by":"crossref","first-page":"S354","DOI":"10.1016\/S0924-977X(09)70538-3","article-title":"Objective and subjective efficacy of ramelteon 4mg in adults with chronic insomnia","volume":"19","author":"Hajak","year":"2009","journal-title":"European Neuropsychopharmacol"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945711002310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945711002310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T04:35:40Z","timestamp":1592973340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945711002310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1389945711002310"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2011.06.008","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}